Advertisement

Topics

Case Study: Vascular Risk Factors Reach Tipping Point

06:25 EDT 15 Sep 2018 | Neurology Times

By the time a 45-year-old patient with hypertension, slurred speech, and weakness in the right arm and right leg was examined in the emergency department, his symptoms had completely disappeared. However, examination, labs, and imaging showed the case was anything but "resolved."

Original Article: Case Study: Vascular Risk Factors Reach Tipping Point

NEXT ARTICLE

More From BioPortfolio on "Case Study: Vascular Risk Factors Reach Tipping Point"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Adempas (riociguat)
The United States Food and Drug Administration (FDA) has approved on October 8th 2013 Adempas® (riociguat) tablets for: (i) the treatment of adults with persistent/recurrent chronic thromboembolic pulmonary hypertension (CTEPH) (WHO* Group 4) after ...